Recombinant human bone morphogenetic protein-2¿Í 2°¡Áö scaffold¸¦ ÀÌ¿ëÇÑ °ñÀ̽ļú: Áõ·Ê¿¬±¸
Bone graft using two types of scaffolds and recombinant human bone morphogenetic protein-2: Case series study
±è¿µ±Õ,
¼Ò¼Ó »ó¼¼Á¤º¸
±è¿µ±Õ ( Kim Young-Kyun ) - ºÐ´ç¼¿ï´ëÇб³º´¿ø Ä¡°ú ±¸°¾Ç¾È¸é¿Ü°ú
KMID : 0353320140380020127
Abstract
The purpose of this study was to evaluate clinical outcome when hydroxyapatite (HA) or demineralized dentin matrix (DDM) and recombinant human bone morphogenetic protein-2 (rhBMP-2) were used together. Bone graft was performed in eight patients using rhBMP-2 and HA or DDM scaffolds. Scaffolds were soaked with 0.5 mg/0.5 mL of rhBMP-2 solution for 10 minutes. Short-term clinical outcome was evaluated using periodic follow-up and radiographic examination. Favorable bony healing was obtained in all cases without any severe complications. Successful prosthetic treatment was completed without any osseointegration failure. In this case series study, rhBMP-2 combined with HA or DDM scaffolds can be used for bone graft procedures such as guided bone regeneration.
Å°¿öµå
Demineralized dentin matrix; Hydroxyapatite; Recombinant human bone morphogenetic protein-2; Scaffold
¿ø¹® ¹× ¸µÅ©¾Æ¿ô Á¤º¸
µîÀçÀú³Î Á¤º¸